Back to Search
Start Over
Preventive effect of Terminalia bellirica on obesity and metabolic disorders in spontaneously obese type 2 diabetic model mice
- Source :
- Journal of Natural Medicines. 66:459-467
- Publication Year :
- 2011
- Publisher :
- Springer Science and Business Media LLC, 2011.
-
Abstract
- Visceral obesity induces insulin resistance and is recognized as an important risk factor for metabolic syndrome (MS). Therefore, inhibition of lipid absorption from the intestine is regarded as an effective way of preventing MS. Terminalia bellirica is extensively used in Ayurvedic medicine in India and neighboring countries, and the fruit of this plant has been reported to have hypoglycemic and hypolipidemic effects. In this study, we investigated the preventive effect of a hot water extract of T. bellirica fruit (TB) on obesity and various metabolic disorders, and explored its molecular mechanisms and active ingredients. TB treatment had a preventive effect on obesity, insulin resistance, and hyperlipidemia in spontaneously obese type 2 diabetic TSOD mice. To clarify the molecular mechanisms of TB in preventing obesity, we investigated the inhibitory effect on lipid absorption. TB suppressed absorption of triacylglycerol in an olive oil loading test (in vivo) and showed a strong inhibitory effect on pancreatic lipase activity (in vitro). Furthermore, a search for the active ingredients in TB revealed that gallic acid is the component primarily responsible for the inhibition of pancreatic lipase activity. Thus, our findings indicate that TB could be useful in preventing MS. The mechanisms probably involve suppression of the absorption of meal-derived lipids mediated by gallic acid.
- Subjects :
- Male
medicine.medical_specialty
Hyperlipidemias
Mice
chemistry.chemical_compound
Insulin resistance
In vivo
Diabetes mellitus
Internal medicine
Hyperlipidemia
Animals
Medicine
Obesity
Gallic acid
biology
Plant Extracts
business.industry
Terminalia
medicine.disease
biology.organism_classification
Endocrinology
Diabetes Mellitus, Type 2
chemistry
Molecular Medicine
Anti-Obesity Agents
Insulin Resistance
Metabolic syndrome
business
Subjects
Details
- ISSN :
- 18610293 and 13403443
- Volume :
- 66
- Database :
- OpenAIRE
- Journal :
- Journal of Natural Medicines
- Accession number :
- edsair.doi.dedup.....1cae03bdfea50e294cf6c1957d4f03ed
- Full Text :
- https://doi.org/10.1007/s11418-011-0606-y